PharmaNutra, a pharmaceutical company, agreed to acquire Akern, a firm engaged in the production and commercialization of medical devices and software for the monitoring of the body composition through bio-impedance techniques, from Red Lions, Jacopo Talluri and Liside for $15m. “The acquisition of Akern represents a turning point for both the companies and a key milestone in the implementation of PharmaNutra’s growth strategy. Akern is a cash generating company with a growing business which will allow the realization of important strategic synergies, starting from 2023, with a boost and diversification of the business lines. Pharmanutra will heavily strengthen its know how benefiting from more than 40 years’ experience of a leading Italian company in the bio-impedance analysis, and it will support Akern in consolidating its presence in the Italian and International markets through our capillary network of distributors," Andrea Lacorte, Pharmanutra Chairman.